Pierre Massion
Faculty Member
Last active: 1/11/2018

  1. Workshop on imaging science development for cancer prevention and preemption. Kelloff GJ, Sullivan DC, Baker H, Clarke LP, Nordstrom R, Tatum JL, Dorfman GS, Jacobs P, Berg CD, Pomper MG, Birrer MJ, Tempero M, Higley HR, Petty BG, Sigman CC, Maley C, Sharma P, Wax A, Ginsberg GG, Dannenberg AJ, Hawk ET, Messing EM, Grossman HB, Harisinghani M, Bigio IJ, Griebel D, Henson DE, Fabian CJ, Ferrara K, Fantini S, Schnall MD, Zujewski JA, Hayes W, Klein EA, DeMarzo A, Ocak I, Ketterling JA, Tempany C, Shtern F, Parnes HL, Gomez J, Srivastava S, Szabo E, Lam S, Seibel EJ, Massion P, McLennan G, Cleary K, Suh R, Burt RW, Pfeiffer RM, Hoffman JM, Roy HK, Wang T, Limburg PJ, El-Deiry WS, Papadimitrakopoulou V, Hittelman WN, MacAulay C, Veltri RW, Solomon D, Jeronimo J, Richards-Kortum R, Johnson KA, Viner JL, Stratton SP, Rajadhyaksha M, Dhawan A, Workshop Program Committee (2007) Cancer Biomark 3(1): 1-33
    › Primary publication · 17655039 (PubMed)
  2. Relevance of nitric oxide for myocardial remodeling. Massion PB, Balligand JL (2007) Curr Heart Fail Rep 4(1): 18-25
    › Primary publication · 17386181 (PubMed)
  3. PDGFR-beta expression in small cell lung cancer patients. Shinohara ET, Gonzalez A, Massion PP, Olson SJ, Albert JM, Shyr Y, Carbone DP, Johnson DH, Hallahan DE, Lu B (2007) Int J Radiat Oncol Biol Phys 67(2): 431-7
    › Primary publication · 17236966 (PubMed)
  4. Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study. Taguchi F, Solomon B, Gregorc V, Roder H, Gray R, Kasahara K, Nishio M, Brahmer J, Spreafico A, Ludovini V, Massion PP, Dziadziuszko R, Schiller J, Grigorieva J, Tsypin M, Hunsucker SW, Caprioli R, Duncan MW, Hirsch FR, Bunn PA, Carbone DP (2007) J Natl Cancer Inst 99(11): 838-46
    › Primary publication · 17551144 (PubMed)
  5. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. Yildiz PB, Shyr Y, Rahman JS, Wardwell NR, Zimmerman LJ, Shakhtour B, Gray WH, Chen S, Li M, Roder H, Liebler DC, Bigbee WL, Siegfried JM, Weissfeld JL, Gonzalez AL, Ninan M, Johnson DH, Carbone DP, Caprioli RM, Massion PP (2007) J Thorac Oncol 2(10): 893-901
    › Primary publication · 17909350 (PubMed) · PMC4220686 (PubMed Central)
  6. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer. Albert JM, Gonzalez A, Massion PP, Chen H, Olson SJ, Shyr Y, Diaz R, Lambright ES, Sandler A, Carbone DP, Putnam JB, Johnson DH, Lu B (2007) Cancer Epidemiol Biomarkers Prev 16(9): 1845-51
    › Primary publication · 17855704 (PubMed)
  7. Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: a potential role for hypoxia. Polosukhin VV, Lawson WE, Milstone AP, Egunova SM, Kulipanov AG, Tchuvakin SG, Massion PP, Blackwell TS (2007) Virchows Arch 451(4): 793-803
    › Primary publication · 17674038 (PubMed)
  8. Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Amann JM, Chaurand P, Gonzalez A, Mobley JA, Massion PP, Carbone DP, Caprioli RM (2006) Clin Cancer Res 12(17): 5142-50
    › Primary publication · 16951232 (PubMed)
  9. Proteomic strategies for the characterization and the early detection of lung cancer. Massion PP, Caprioli RM (2006) J Thorac Oncol 1(9): 1027-39
    › Primary publication · 17409991 (PubMed)
  10. PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Gallia GL, Rand V, Siu IM, Eberhart CG, James CD, Marie SK, Oba-Shinjo SM, Carlotti CG, Caballero OL, Simpson AJ, Brock MV, Massion PP, Carson BS, Riggins GJ (2006) Mol Cancer Res 4(10): 709-14
    › Primary publication · 17050665 (PubMed)